Semler Scientific, Inc.
DelistedCIK 1554859fmd_0J7R75KDPAGXDGTPZEC2XAA68HManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2025, 51 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 7 | 7 | 12 | 21 | 33 | 39 | 53 | 57 | 68 | 56 |
| Rental revenue | – | – | – | – | 23 | 26 | 31 | 34 | 37 | 27 |
| Cost of revenue | 3 | 2 | 3 | 3 | 4 | 3 | 6 | 4 | 7 | 5 |
| Net interest income | – | – | – | (0) | 0 | 0 | 0 | 0 | – | – |
| Gross profit | 4 | 6 | 10 | 19 | 29 | 35 | 47 | 52 | 61 | 52 |
| Realized investment gains (losses) | – | – | – | – | – | 0 | – | – | – | – |
| Research and development | – | – | – | – | – | – | – | 4 | 6 | 5 |
| Selling, general and administrative | 11 | 7 | 9 | 11 | 16 | 16 | 24 | 30 | 32 | 26 |
| Total operating expenses | 15 | 10 | 13 | 16 | – | – | – | – | – | – |
| Operating income | (8) | (2) | (1) | 5 | 11 | 16 | 19 | 17 | 22 | 21 |
| Interest expense | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Interest and investment income | – | – | – | – | – | – | – | 0 | 2 | 2 |
| Other non-operating income (expense) | (0) | (0) | (1) | (0) | (0) | 1 | 0 | 0 | 2 | 27 |
| Income before taxes | – | – | (2) | 5 | 11 | 16 | 19 | 18 | 24 | 48 |
| Income tax expense | 0 | 0 | 0 | 0 | (4) | 2 | 2 | 3 | 4 | 7 |
| Net income from continuing operations | – | – | (2) | 5 | 15 | 14 | 17 | 14 | 21 | 41 |
| Net income | (9) | (3) | (2) | 5 | 15 | 14 | 17 | 14 | 21 | 41 |
| Net income to common shareholders | – | – | (2) | 5 | 15 | 14 | 17 | 14 | 21 | 41 |